The Christine E. Lynn Women’s Health & Wellness Institute (LWHWI) at Boca Raton Regional Hospital announced that it has added the GE Healthcare Invenia Automated Breast Ultrasound System (ABUS) to the facility’s spectrum of breast imaging capabilities. The hospital reports that, for women with dense breast tissue, ABUS provides a good supplemental screening option that, when combined with traditional mammography, has been shown to increase the detection of cancer by nearly 55%.
According to GE, the Invenia ABUS is the only ultrasound device in the United States to be approved by the FDA as an adjunct technology that can be used in conjunction with mammography for breast cancer screening in asymptomatic women with dense breast tissue.
The ABUS uses a transducer that is shaped to a woman’s body in order to provide good image performance, enhanced breast coverage, and patient comfort. The system’s high-resolution touchscreen display and improved workflow reduces procedural time, and allows generated images to be sent directly to a workstation for quick interpretation and archiving.
“There is a dramatic paradigm shift in the approach to screening mammography that now recognizes the difference in women’s breast tissue and the clinical implications of those differences,” said Kathy Schilling, MD, Medical Director of LWHWI. “The addition of ABUS now gives our Women’s Institute every tool possible to customize our screening protocols per a woman’s specific needs and detect breast cancer at its earliest and most curable stage.”
For more information about the Invenia Automated Breast Ultrasound System, visit the GE Healthcare website.
